Intravitreal aflibercept (IVT-AFL) for macular edema secondary to CRVO: Results of COPERNICUS and GALILEO studies

被引：0
|
作者：
Creuzot, C. [1 ]
机构：
[1] Dept Ophthalmol, Djon, France
来源：
ACTA OPHTHALMOLOGICA | 2013年 / 91卷
关键词：
D O I：
10.1111/j.1755-3768.2013.4714.x
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4714
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Visual Acuity Outcomes in Dosing Subgroups of the GALILEO and COPERNICUS study in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) Under PRN Treatment
    Pielen, Amelie
    Haller, Julia
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [22] INTRAVITREAL AFLIBERCEPT (IVT-AFL) WITH AND WITHOUT PHOTODYNAMIC THERAPY (PDT) IN POLYPOIDAL CHOROIDAL VASCULOPATHY (PCV): ANATOMICAL OUTCOMES ASSESSED BY OPTICAL COHERENCE TOMOGRAPHY (OCT) IN THE PLANET STUDY
    Mitchell, Paul
    Wong, Tien
    Lee, Won Ki
    Cheung, Gemmy
    Zhang, Zhongqi
    Ogura, Yuichiro
    Leal, Sergio
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 45 : 31 - 32
  • [23] Treatment Experience with Intravitreal Aflibercept Injection (IAI) After Switching to PRN Dosing in Patients with Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)
    Brown, David
    Holz, Frank
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [24] Simultaneous intravitreal dexamethasone and aflibercept for refractory macular edema secondary to retinal vein occlusion
    Giuffre, Chiara
    Cicinelli, Maria Vittoria
    Marchese, Alessandro
    Coppola, Michele
    Parodi, Maurizio Battaglia
    Bandello, Francesco
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2020, 258 (04) : 787 - 793
  • [25] Simultaneous intravitreal dexamethasone and aflibercept for refractory macular edema secondary to retinal vein occlusion
    Chiara Giuffrè
    Maria Vittoria Cicinelli
    Alessandro Marchese
    Michele Coppola
    Maurizio Battaglia Parodi
    Francesco Bandello
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2020, 258 : 787 - 793
  • [26] Efficacy and safety of intravitreal aflibercept (IVT-AFL) treat-and-extend (T&E) compared with fixed dosing (q8) for neovascular age-related macular degeneration (nAMD): The AZURE study
    Kodjikian, Laurent
    Arias Barquet, Lluis
    Papp, Andras
    Kertes, Peter
    Midena, Edoardo
    Ernest, Jan
    Silva, Rufino
    Schmelter, Thomas
    Niesen, Tobias
    Leal, Sergio
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [27] Intravitreal ziv-aflibercept for recurrent macular edema secondary to central retinal venous occlusion
    Chhablani, Jay
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2015, 63 (05) : 469 - 470
  • [28] Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
    Wang, Jia-Kang
    Su, Pei-Yuan
    Hsu, Yung-Ray
    Chen, Yun-Ju
    Chen, Fang-Ting
    Tseng, Ying-Yu
    JOURNAL OF OPHTHALMOLOGY, 2016, 2016
  • [29] Intravitreal Ranibizumab Versus Aflibercept for Diabetic Macular Edema in Vitrectomized Eyes: 12 Month Results
    Turkseven Kumral, Esra
    Ercalik, Nimet Yesim
    SEMINARS IN OPHTHALMOLOGY, 2021, 36 (08) : 723 - 727
  • [30] Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion One-Year Results of the Phase 3 GALILEO Study
    Korobelnik, Jean-Francois
    Holz, Frank G.
    Roider, Johann
    Ogura, Yuichiro
    Simader, Christian
    Schmidt-Erfurth, Ursula
    Lorenz, Katrin
    Honda, Miki
    Vitti, Robert
    Berliner, Alyson J.
    Hiemeyer, Florian
    Stemper, Brigitte
    Zeitz, Oliver
    Sandbrink, Rupert
    OPHTHALMOLOGY, 2014, 121 (01) : 202 - 208
12345